Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma
{{output}}
The impact of fludarabine pharmacokinetics (PK) on chimeric antigen receptor (CAR) T-cell outcomes is not fully elucidated. We hypothesized that, in relapsed/refractory (R/R) large B-cell lymphoma (LBCL) patients, measured fludarabine exposure during lymphodep... ...
